Profitability Ratios
| Ratio |
Value |
| GP Margin |
72.8% |
| EBIT Margin |
35.6% |
| EBITDA Margin |
43.6% |
| Operating Margin |
27.2% |
| Pretax Margin |
34.6% |
| Cont. Ops Margin |
28.5% |
| Net Margin |
28.5% |
| Bottom Line Margin |
28.5% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.03 |
| Quick Ratio |
0.77 |
| Solvency Ratio |
0.292 |
| Cash Ratio |
0.36 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.21 |
| Forward PEG |
0.21 |
| Price/Book |
6.18 |
| Price/Sales |
5.35 |
| Price/FCF |
25.59 |
| Price/Op Cash Flow |
20.55 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.2406 |
| Debt/Equity |
0.5878 |
| Debt/Capital |
0.3702 |
| Long-Term Debt/Capital |
0.3260 |
| Financial Leverage |
2.44 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
26.65 |
| Operating Cash Flow Ratio |
0.453 |
| Operating Cash Flow/Sales |
26.0% |
| Free Cash Flow/Operating Cash Flow |
80.3% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
3.73 |
| Interest Coverage |
26.3605 |
| Short-Term Operating Cash Flow Coverage |
2.89 |
| Operating Cash Flow Coverage |
0.51 |
| Capital Expenditure Coverage |
5.08 |
| Dividend + Capital Expenditure Coverage |
1.43 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
46.1909% |
| Dividend Yield |
2.4562% |
| Dividend Yield % |
2.4562% |
| Dividend Per Share |
5.0980 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
38.78 |
| EPS |
11.037 |
| Debt/Share |
20.1367 |
| Cash/Share |
8.28 |
| Book Value/Share |
33.58 |
| Tangible BV/Share |
-7.26 |
| Equity/Share |
33.58 |
| Operating Cash Flow/Share |
10.100 |
| Capital Expenditure/Share |
1.990 |
| FCF/Share |
8.111 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.823 |
| Earnings Before Tax/EBIT |
1.273 |
| Price/Fair Value |
6.18 |
| Debt/Market Cap |
0.0951 |
| Effective Tax Rate |
17.7% |
| Enterprise Value Multiple |
12.97 |
JNJ - Johnson & Johnson